-
Targeted cell-free DNA analysis with microarray quantitation for assessment of fetal sex and sex chromosome aneuploidy risk.
Jones KJ, Wang E, Bogard P, White K, Schmid M, Stokowski R, Nicolaides KH.
Ultrasound Obstet Gynecol 2018;51:275-276. pdf -
Imaging single DNA molecules for high precision NIPT.
Dahl F, Ericsson O, Karlberg O, Karlsson F, Howell M, Persson F, Roos F, Stenberg J, Ahola T, Alftrén I, Andersson B, Barkenäs E, Brandner B, Dahlberg J, Elfman S, Eriksson M, Forsgren PO, Francois N, Gousseva A, Hakamali F, Janfalk-Carlsson Å, Johansson H, Lundgren J, Mohsenchian A, Olausson L, Olofsson S, Qureshi A, Skarpås B, Sävneby A, Åström E, Öhman O, Westgren M, Kopp-Kallner H, Fianu-Jonasson A, Syngelaki A, Nicolaides K.
Sci Rep 2018;8:4549. pdf -
Fetal aneuploidy diagnosed at celocentesis for early prenatal diagnosis of congenital hemoglobinopathies.
Giambona A, Leto F, Passarello C, Vinciguerra M, Cigna V, Schillaci G, Picciotto F, Lauricella S, Nicolaides KH, Makrydimas G, Damiani G, Maggio A.
Acta Obstet Gynecol Scand 2018;97:312-321. pdf